Best deals to access real time data!
SMALL CAP PRO
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
VAT not included
|Company Name||Stock Ticker Symbol||Market||Type||ISIN|
|Polydex Pharmaceuticals Ltd. (PC)||POLXF||Other OTC||Common Stock|
|Price Change||Change Percent||Stock Price||High Price||Low Price||Open Price||Close Price||Last Traded|
|Bid Price||Ask Price||Spread||Spread %||News|
|Last Trade Time||Type||Quantity||Stock Price||Currency|
Polydex Pharmaceuticals Ltd. (PC) Financials
|Market Cap||Shares in Issue||Profit/Loss||Earnings Per Share (EPS)||PE Ratio||Float|
|$ 5.98M||3.38M||$ -1.59M||-||-||2.42M|
|Short Interest||Dividends Per Share||Dividend Yield||Ex-Div Date||Insider B/S||Insider % Owned|
Polydex Pharmaceuticals Ltd. (PC) News
Real-Time news about Polydex Pharmaceuticals Ltd. (PC) (Other OTC): 0 recent articles
Historical POLXF Price Data
|Period †||Open||High||Low||VWAP||Min Vol||Max Vol||Avg. Daily Vol [m]||Change||%|
Polydex Pharmaceuticals Ltd. (PC) Description
|Polydex Pharmaceuticals Limited (the "Company") is engaged in the research, development, manufacture and marketing of biotechnology-based products for the veterinary and human pharmaceutical markets. This includes the manufacture of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry. The Company focuses on the manufacture and sale of Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals. Dextran, a generic name applied to certain synthetic compounds formed by bacterial growth on sucrose, is a polymer or giant molecule. The name Polydex combines the words "polymer" and "dextran."
The Company conducts its business operations through its two wholly-owned subsidiaries. The manufacture and sale of Dextran and derivative products is conducted through Dextran Products Limited, incorporated in Canada in 1966 (Dextran Products),and Chemdex Inc (Chemdex) which is incorporated in the state of Kansas, United States.
FOR ADDITIONAL FINANCIAL INFORMATION AND NEWS, INCLUDING MORE RECENT QUARTERLY REPORTING, PLEASE VISIT OUR WEBSITE!